FdaApplication
NDA 018164
Identifiers
- fda_app_no: NDA018164
Properties
| Property | Value |
|---|---|
| applicant_name | ATNAHS PHARMA US LTD |
| application_type | NDA |
| approval_date | 1987-09-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANAPROX | NAPROXEN SODIUM | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ANAPROX DS | NAPROXEN SODIUM | EQ 500MG BASE | TABLET;ORAL |
2 products